B

Boryung Corp
KRX:003850

Watchlist Manager
Boryung Corp
KRX:003850
Watchlist
Price: 9 080 KRW -2.78%
Market Cap: 779B KRW

Relative Value

The Relative Value of one Boryung Corp stock under the Base Case scenario is hidden KRW. Compared to the current market price of 9 080 KRW, Boryung Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Boryung Corp Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
75
Median 3Y
0.8
Median 5Y
0.8
Industry
2.6
Forward
0.7
vs History
15
vs Industry
37
Median 3Y
14.9
Median 5Y
18.7
Industry
21.6
Forward
13.5
vs History
66
vs Industry
38
Median 3Y
10.6
Median 5Y
13.1
Industry
16.5
vs History
50
vs Industry
7
Median 3Y
4.3
Median 5Y
6
Industry
22.5
vs History
84
vs Industry
61
Median 3Y
1.1
Median 5Y
1.3
Industry
2.3
vs History
68
vs Industry
78
Median 3Y
0.9
Median 5Y
0.9
Industry
2.9
Forward
0.8
vs History
44
vs Industry
70
Median 3Y
2.3
Median 5Y
2.4
Industry
5.5
vs History
42
vs Industry
42
Median 3Y
7.4
Median 5Y
7.6
Industry
13
Forward
7.2
vs History
60
vs Industry
36
Median 3Y
12.2
Median 5Y
12.7
Industry
16.6
Forward
11.3
vs History
66
vs Industry
40
Median 3Y
11.6
Median 5Y
15.8
Industry
15.8
vs History
34
vs Industry
29
Median 3Y
16.1
Median 5Y
14.9
Industry
19.1
vs History
76
vs Industry
63
Median 3Y
0.9
Median 5Y
1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Boryung Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Boryung Corp
KRX:003850
767.1B KRW 0.8 24.1 7.5 12.1
US
Eli Lilly and Co
NYSE:LLY
999.6B USD 16.8 54.3 36.4 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
501.2B USD 5.4 20 16.3 21.2
CH
Roche Holding AG
SIX:ROG
254.4B CHF 4.1 27 11.5 13.5
UK
AstraZeneca PLC
LSE:AZN
210.1B GBP 4.8 29.9 108.3 158.5
CH
Novartis AG
SIX:NOVN
206.7B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
250.5B USD 3.9 13.2 9.4 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13 9.1 10.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
142.4B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
KR
B
Boryung Corp
KRX:003850
Average P/E: 23.8
24.1
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
54.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
27
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
B
Boryung Corp
KRX:003850
Average EV/EBITDA: 399.5
7.5
3%
2.5
US
Eli Lilly and Co
NYSE:LLY
36.4
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
B
Boryung Corp
KRX:003850
Average EV/EBIT: 1 711.2
12.1
8%
1.5
US
Eli Lilly and Co
NYSE:LLY
39.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.5
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3